Discovery and development of a synthetic peptide derived from lactoferrin for clinical use

Peptides

Volumn 32, Issue 9, 2011, Pages 1953-1963

  Brouwer, Carlo P J M ^a   Rahman, Mahfuzur ^b   Welling, Mick M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NAEJA Pharmaceuticals Inc   (Canada)

Author keywords

Antimicrobial peptide; Clinical trial; hLF(1 11); Infection; Lactoferrin; Synthetic derivate

Indexed keywords

AMINO ACID DERIVATIVE; ANTIBIOTIC AGENT; CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; LACTOFERRIN; POLYPEPTIDE ANTIBIOTIC AGENT; SYNTHETIC PEPTIDE;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTEREMIA; CLINICAL TRIAL; CROHN DISEASE; DIARRHEA; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INFECTION; ISOTOPE LABELING; LUNG NON SMALL CELL CANCER; MENINGITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CANDIDA; CHEMISTRY TECHNIQUES, SYNTHETIC; CLINICAL TRIALS AS TOPIC; DRUG DISCOVERY; DRUG EVALUATION; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; HUMANS; LACTOFERRIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MOLECULAR SEQUENCE DATA; MYCOSES; PEPTIDE FRAGMENTS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 80052724738     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.07.017     Document Type: Review

References (145)

1. M.S. Akhtar, A. Qaisar, J. Irfanullah, J. Iqbal, B. Khan, and M. Jehangir Antimicrobial peptide Tc-99m-ubiquicidin 29-41 as human infection-imaging agent: clinical trial J Nucl Med 46 4 2005 567 573 (Pubitemid 41716399)
2. M. Akhtari, S.M. Hossain, P. Forghani, and E.K. Waller Oral human recombinant lactoferrin prevents acute graft-versus-host disease and stimulates reconstitution of donor bone marrow-derived T-cells in a mouse model of bone marrow transplantation Biol Blood Marrow Transplant 16 2, Suppl. 1 2010 S305
3. J.H. Andersen, H. Jenssen, and T.J. Gutteberg Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir Antiviral Res 58 3 2003 209 215 (Pubitemid 36589011)
4. E. Andres, and J.L. Dimarcq Cationic antimicrobial peptides: update of clinical development J Intern Med 255 4 2004 519 520 (Pubitemid 38446366)
5. D. Baev, X.S. Li, J. Dong, P. Keng, and M. Edgerton Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans Infect Immun 70 9 2002 4777 4784
6. E.N. Baker, and H.M. Baker A structural framework for understanding the multifunctional character of lactoferrin Biochimie 91 1 2009 3 10
7. W. Bellamy, M. Takase, H. Wakabayashi, K. Kawase, and M. Tomita Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin J Appl Bacteriol 73 6 1992 472 479
8. W. Bellamy, H. Wakabayashi, M. Takase, K. Kawase, S. Shimamura, and M. Tomita Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin Med Microbiol Immunol 182 2 1993 97 105 (Pubitemid 23160081)
9. N.O.R.E. Benkerroum Antimicrobial peptides generated from milk proteins: a survey and prospects for application in the food industry. A review Int J Dairy Technol 63 3 2010 320 338
10. E. Biron, and N. Voyer Synthesis of cationic porphyrin modified amino acids Chem Commun (Camb) 37 2005 4652 4654 (Pubitemid 41475743)
11. G. Boheim Statistical analysis of alamethicin channels in black lipid membranes J Membr Biol 19 3 1974 277 303
12. H.G. Boman, B. Agerberth, and A. Boman Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine Infect Immun 61 7 1993 2978 2984 (Pubitemid 23182296)
13. Y. Borel, R. Fritsche, H. Borel, U. Dahlgren, A. Dalhman-Hoglund, and L.A. Hanson Parenteral and oral administration of tolerogens: protein-IgG conjugates Ann N Y Acad Sci 778 1996 80 87 (Pubitemid 26145535)
14. E. Breukink, K.C. van, R.A. Demel, R.J. Siezen, O.P. Kuipers, and K.B. de The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane Biochemistry 36 23 1997 6968 6976 (Pubitemid 27258109)
15. Brouwer CP, Bogaards SJ, Welling MM, Velders MP, Nibbering PH. The highly effective antimicrobial peptide hLF 1-11 may be given to (immunocompromised) mice with a multidrug-resistant Staphylococcus aureus infection by various routes. 45th Interscience Conference on Antimicrobial agents and Chemotherapy, Washington, USA, December 16-19, 2005; Session B2-18L.
16. C.P. Brouwer, F.F. Gemmel, and M.M. Welling Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental multidrug-resistant Staphylococcus aureus bacterial endocarditis Q J Nucl Med Mol Imaging 54 4 2010 442 450
17. Brouwer CP, Lupetti A, Wulferink M, Jonk L, Velders MP, Nibbering PH. Antifungal activities of the human lactoferrin-derived peptide hLF(1-11) against a disseminated Candida albicans infection. 46th Interscience Conference on Antimicrobial agents and Chemotherapy, San Francisco, USA, September 27-30, 2006; Session 150 B-1331.
18. C.P. Brouwer, L. Sarda-Mantel, A. Meulemans, G.D. Le, and M.M. Welling The use of technetium-99m radiolabeled human antimicrobial peptides for infection specific imaging Mini Rev Med Chem 8 10 2008 1039 1052
19. C.P. Brouwer, and M.M. Welling Various routes of administration of (99m)Tc-labeled synthetic lactoferrin antimicrobial peptide hLF 1-11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice Peptides 29 7 2008 1109 1117
20. C.P. Brouwer, M. Wulferink, and M.M. Welling The pharmacology of radiolabeled cationic antimicrobial peptides J Pharm Sci 97 5 2008 1633 1651
21. E.M. Caraher, K. Gumulapurapu, C.C. Taggart, P. Murphy, S. McClean, and M. Callaghan The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms J Antimicrob Chemother 60 3 2007 546 554 (Pubitemid 47299868)
22. A. Carlsson, P. Engstrom, E.T. Palva, and H. Bennich Attacin, an antibacterial protein from Hyalophora cecropia, inhibits synthesis of outer membrane proteins in Escherichia coli by interfering with omp gene transcription Infect Immun 59 9 1991 3040 3045
23. A.M. Cole, T. Hong, L.M. Boo, T. Nguyen, C. Zhao, and G. Bristol Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1 Proc Natl Acad Sci U S A 99 4 2002 1813 1818 (Pubitemid 34168972)
24. J. Cornish, K.E. Callon, D. Naot, K.P. Palmano, T. Banovic, and U. Bava Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo Endocrinology 145 9 2004 4366 4374 (Pubitemid 39120586)
25. F. Costa, I.F. Carvalho, R.C. Montelaro, P. Gomes, and M.C. Martins Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces Acta Biomater 7 4 2011 1431 1440
26. M. Cudic, B.A. Condie, D.J. Weiner, E.S. Lysenko, Z.Q. Xiang, and O. Insug Development of novel antibacterial peptides that kill resistant isolates Peptides 23 12 2002 2071 2083 (Pubitemid 36092040)
27. M. Cudic, C.V. Lockatell, D.E. Johnson, and L. Otvos Jr. In vitro and in vivo activity of an antibacterial peptide analog against uropathogens Peptides 24 6 2003 807 820 (Pubitemid 37011427)
28. A.L. Den Hertog, H.W. Wong Fong Sang, R. Kraayenhof, J.G. Bolscher, W. van't Hof, and E.C. Veerman Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization Biochem J 379 Pt 3 2004 665 672 (Pubitemid 38703650)
29. E.J. Dial, J.J. Romero, D.R. Headon, and L.M. Lichtenberger Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice J Pharm Pharmacol 52 12 2000 1541 1546 (Pubitemid 32058654)
30. L. Dijkshoorn, C.P. Brouwer, S.J. Bogaards, A. Nemec, P.J. Van den Broek, and P.H. Nibbering The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 48 12 2004 4919 4921 (Pubitemid 39577708)
31. D.A. Dionysius, and J.M. Milne Antibacterial peptides of bovine lactoferrin: purification and characterization J Dairy Sci 80 4 1997 667 674 (Pubitemid 127446978)
32. K. Dzitko, B. Dziadek, J. Dziadek, and H. Dlugonska Toxoplasma gondii: inhibition of the intracellular growth by human lactoferrin Pol J Microbiol 56 1 2007 25 32 (Pubitemid 46814167)
33. M. El-Loly, and M.B. Mahfouz Lactoferrin in relation to biological functions and applications: a review Int J Dairy Sci 6 2 2011 79 111
34. L.T. Eliassen, G. Berge, A. Leknessund, M. Wikman, I. Lindin, and C. Løkke The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo Int J Cancer 119 3 2006 493 500 (Pubitemid 43955700)
35. C. Faber, H.P. Stallmann, D.M. Lyaruu, U. Joosten, E.C. von, and A.A. van Nieuw Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model Antimicrob Agents Chemother 49 6 2005 2438 2444 (Pubitemid 40734477)
36. M.J. Facon, and B.J. Skura Antibacterial activity of lactoferricin, lysozyme and EDTA against Salmonella enteritidis Int Dairy J 6 3 1996 303 313 (Pubitemid 27094033)
37. T.J. Falla, D.N. Karunaratne, and R.E. Hancock Mode of action of the antimicrobial peptide indolicidin J Biol Chem 271 32 1996 19298 19303 (Pubitemid 26271598)
38. S. Farnaud, and R.W. Evans Lactoferrin - a multifunctional protein with antimicrobial properties Mol Immunol 40 7 2003 395 405 (Pubitemid 37244032)
39. J.L. Flanagan, and M.D. Willcox Role of lactoferrin in the tear film Biochimie 91 1 2009 35 43
40. S. Fornili, R. Pizzi, and D. Rebeccani Conformational analysis of a synthetic antimicrobial peptide in water and membrane-mimicking solvents: a molecular dynamics simulation study Int J Pept Res Ther 16 4 2010 223 231
41. M. Gahr, C.P. Speer, B. Damerau, and G. Sawatzki Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes J Leukoc Biol 49 5 1991 427 433
42. T. Ganz, and Chemistry Rings of destruction Nature 412 6845 2001 392 393
43. T. Ganz, and R.I. Lehrer Antimicrobial peptides of vertebrates Curr Opin Immunol 10 1 1998 41 44 (Pubitemid 28112077)
44. F. Gemmel, N. Dumarey, and M. Welling Future diagnostic agents Semin Nucl Med 39 1 2009 11 26
45. S.A. González-Chávez, S. Arévalo-Gallegos, and Q. Rascón-Cruz Lactoferrin: structure, function and applications Int J. Antimicrob Agents 33 4 2009 301
46. Y.J. Gordon, E.G. Romanowski, and A.M. McDermott A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs Curr Eye Res 30 7 2005 505 515 (Pubitemid 41113552)
47. R.E. Hancock Peptide antibiotics Lancet 349 9049 1997 418 422 (Pubitemid 27077684)
48. R.E. Hancock Cationic antimicrobial peptides: towards clinical applications Expert Opin Investig Drugs 9 8 2000 1723 1729 (Pubitemid 30639323)
49. R.E. Hancock Cationic peptides: effectors in innate immunity and novel antimicrobials Lancet Infect Dis 1 3 2001 156 164 (Pubitemid 33586049)
50. R.E. Hancock, and R. Lehrer Cationic peptides: a new source of antibiotics Trends Biotechnol 16 2 1998 82 88 (Pubitemid 28055477)
51. E.F. Haney, K. Nazmi, F. Lau, J.G. Bolscher, and H.J. Vogel Novel lactoferrampin antimicrobial peptides derived from human lactoferrin Biochimie 91 1 2009 141 154
52. M.R. Harris, and P.J. Coote Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro Int J Antimicrob Agents 35 4 2010 347 356
53. B.E. Haug, M.B. Strom, and J.S. Svendsen The medicinal chemistry of short lactoferricin-based antibacterial peptides Curr Med Chem 14 1 2007 1 18 (Pubitemid 46050301)
54. L. Haversen, N. Kondori, L. Baltzer, L.A. Hanson, G.T. Dolphin, and K. Duner Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin Antimicrob Agents Chemother 54 1 2010 418 425
55. L.A. Haversen, I. Engberg, L. Baltzer, G. Dolphin, L.A. Hanson, and I. Mattsby-Baltzer Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice Infect Immun 68 10 2000 5816 5823
56. E.J. Helmerhorst, P. Breeuwer, W. van't Hof, E. Walgreen-Weterings, L.C. Oomen, and E.C. Veerman The cellular target of histatin 5 on Candida albicans is the energized mitochondrion J Biol Chem 274 11 1999 7286 7291
57. E.J. Helmerhorst, R.F. Troxler, and F.G. Oppenheim The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species Proc Natl Acad Sci U S A 98 25 2001 14637 14642 (Pubitemid 33121444)
58. A. Ito, T. Ogishima, W. Ou, T. Omura, H. Aoyagi, and S. Lee Effects of synthetic model peptides resembling the extension peptides of mitochondrial enzyme precursors on import of the precursors into mitochondria J Biochem 98 6 1985 1571 1582 (Pubitemid 16169191)
59. H. Jenssen, P. Hamill, and R.E. Hancock Peptide antimicrobial agents Clin Microbiol Rev 19 3 2006 491 511 (Pubitemid 44137212)
60. H. Jenssen, and R.E. Hancock Antimicrobial properties of lactoferrin Biochimie 91 1 2009 19 29
61. E.M. Jones, A. Smart, G. Bloomberg, L. Burgess, and M.R. Millar Lactoferricin, a new antimicrobial peptide J Appl Bacteriol 77 2 1994 208 214 (Pubitemid 24257218)
62. Jonk L, Brouwer CPJM, Wulferink M, Bogaards SJ, Dousset M, Liskamp R, et al. Antimicrobial activity of the human lactoferrin-derived peptide hLF 1-11 against multi-resistant micro-organisms. 47th Interscience Conference on Antimicrobial agents and Chemotherapy, Chicago, Illinois, USA, September 16-20, 2007; B-827.
63. B.L. Kagan, M.E. Selsted, T. Ganz, and R.I. Lehrer Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes Proc Natl Acad Sci U S A 87 1 1990 210 214
64. T.G. Kanyshkova, S.E. Babina, D.V. Semenov, N. Isaeva, A.V. Vlassov, and K.N. Neustroev Multiple enzymic activities of human milk lactoferrin Eur J Biochem 270 16 2003 3353 3361 (Pubitemid 37011629)
65. D.H. Kim, D.G. Lee, K.L. Kim, and Y. Lee Internalization of tenecin 3 by a fungal cellular process is essential for its fungicidal effect on Candida albicans Eur J Biochem 268 16 2001 4449 4458 (Pubitemid 32862854)
66. W. Klootwijk, E. Sleddens-Linkels, B.R. de, C.A. Jansen, R. Autar, and W.W. de Herder Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans J Clin Endocrinol Metab 82 9 1997 3068 3073 (Pubitemid 27385674)
67. N. Kondori, L. Baltzer, G.T. Dolphin, and I. Mattsby-Baltzer Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial alphabeta region Int J Antimicrob Agents 37 1 2011 51 57
68. P. Lacasse, K. Lauzon, M.S. Diarra, and D. Petitclerc Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens J Anim Sci 86 13 Suppl 2008 66 71
69. H.Y. Lee, J.H. Park, S.H. Seok, M.W. Baek, D.J. Kim, and B.H. Lee Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes in mice J Med Microbiol 54 Pt 11 2005 1049 1054
70. D. Legrand, A. Pierce, E. Elass, M. Carpentier, C. Mariller, and J. Mazurier Lactoferrin structure and functions Adv Exp Med Biol 606 2008 163 194
71. N. Leon-Sicairos, F. Lopez-Soto, M. Reyes-Lopez, D. Godinez-Vargas, C. Ordaz-Pichardo, and M. de la Garza Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme Clin Med Res 4 2 2006 106 113 (Pubitemid 44047363)
72. M.F. Lima, and F. Kierszenbaum Lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes J Immunol 134 6 1985 4176 4183 (Pubitemid 15029647)
73. F. Lopez-Soto, N. Leon-Sicairos, K. Nazmi, J.G. Bolscher, and M. de la Garza Microbicidal effect of the lactoferrin peptides lactoferricin17-30, lactoferrampin265-284, and lactoferrin chimera on the parasite Entamoeba histolytica Biometals 23 3 2010 563 568
74. A. Lupetti, C.P. Brouwer, H.E. Dogterom-Ballering, S. Senesi, M. Campa, and J.T. van Dissel Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin J Antimicrob Chemother 54 3 2004 603 608 (Pubitemid 39263900)
75. A. Lupetti, A. Paulusma-Annema, S. Senesi, M. Campa, J.T. van Dissel, and P.H. Nibbering Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin Antimicrob Agents Chemother 46 6 2002 1634 1639 (Pubitemid 34535175)
76. A. Lupetti, A. Paulusma-Annema, M.M. Welling, H. Dogterom-Ballering, C.P. Brouwer, and S. Senesi Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species Antimicrob Agents Chemother 47 1 2003 262 267 (Pubitemid 36070373)
77. A. Lupetti, A. Paulusma-Annema, M.M. Welling, S. Senesi, J.T. van Dissel, and P.H. Nibbering Candidacidal activities of human lactoferrin peptides derived from the N terminus Antimicrob Agents Chemother 44 12 2000 3257 3263 (Pubitemid 33009481)
78. A. Lupetti, J.T. van Dissel, C.P. Brouwer, and Nibbering PH Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus Eur J Clin Microbiol Infect Dis 27 11 2008 1125 1129
79. A. Lupetti, M.M. Welling, U. Mazzi, P.H. Nibbering, and E.K. Pauwels Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections Eur J Nucl Med Mol Imaging 29 5 2002 674 679 (Pubitemid 34439329)
80. A. Lupetti, M.M. Welling, E.K. Pauwels, and P.H. Nibbering Radiolabelled antimicrobial peptides for infection detection Lancet Infect Dis 3 4 2003 223 229 (Pubitemid 36389185)
81. M.S. Mannoor, S. Zhang, A.J. Link, and M.C. McAlpine Electrical detection of pathogenic bacteria via immobilized antimicrobial peptides Proc Natl Acad Sci U S A 107 45 2010 19207 19212
82. K. Matsuzaki, K. Sugishita, N. Ishibe, M. Ueha, S. Nakata, and K. Miyajima Relationship of membrane curvature to the formation of pores by magainin 2 Biochemistry 37 34 1998 11856 11863 (Pubitemid 28400057)
83. J. Mazurier, D. Legrand, W.L. Hu, J. Montreuil, and G. Spik Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography Eur J Biochem 179 2 1989 481 487 (Pubitemid 19051587)
84. J.B. McPhee, and R.E. Hancock Function and therapeutic potential of host defence peptides J Pept Sci 11 11 2005 677 687 (Pubitemid 41684254)
85. J.B. McPhee, M.G. Scott, and R.E. Hancock Design of host defence peptides for antimicrobial and immunity enhancing activities Comb Chem High Throughput Screen 8 3 2005 257 272
86. L. Melendez-Alafort, J. Rodriguez-Cortes, G. Ferro-Flores, C.A. De Murphy, R. Herrera-Rodriguez, and E. Mitsoura Biokinetics of Tc-99m-UBI 29-41 in humans Nucl Med Biol 31 3 2004 373 379
87. K. Miller, C. Meredith, I. Selo, and J.M. Wal Allergy to bovine beta-lactoglobulin: specificity of immunoglobulin E generated in the Brown Norway rat to tryptic and synthetic peptides Clin Exp Allergy 29 12 1999 1696 1704 (Pubitemid 30012429)
88. A.S. Naidu, R.S. Fowler, C. Martinez, J. Chen, and J. Tulpinski Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates J Reprod Med 49 10 2004 800 807 (Pubitemid 39431176)
89. P.H. Nibbering, E. Ravensbergen, M.M. Welling, L.A. van Berkel, P.H. van Berkel, and E.K. Pauwels Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria Infect Immun 69 3 2001 1469 1476 (Pubitemid 32187596)
90. P.H. Nibbering, M.M. Welling, A. Paulusma-Annema, C.P. Brouwer, A. Lupetti, and Pauwels EK 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus J Nucl Med 45 2 2004 321 326 (Pubitemid 47618657)
91. A. Nijnik, and R.E.W. Hancock Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections Emerg Health Threats J 2 2009 e1
92. K. Nishiya, and D.A. Horwitz Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity J Immunol 129 6 1982 2519 2523 (Pubitemid 13245514)
93. L. Otvos Jr. Antibacterial peptides and proteins with multiple cellular targets J Pept Sci 11 11 2005 697 706 (Pubitemid 41684256)
94. L. Otvos Jr., M. Cudic, B.Y. Chua, G. Deliyannis, and D.C. Jackson An insect antibacterial peptide-based drug delivery system Mol Pharm 1 3 2004 220 232
95. A.L. Panlilio, D.H. Culver, R.P. Gaynes, S. Banerjee, T.S. Henderson, and J.S. Tolson Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991 Infect Control Hosp Epidemiol 13 10 1992 582 586
96. M. Perry, and A. Whyte Immunology of the tonsils Immunol Today 19 9 (September) 1998 414 421 (Pubitemid 28389703)
97. B.M. Peters, M.E. Shirtliff, and M.A. Jabra-Rizk Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog 6 10 2010 e1001067
98. P. Puddu, P. Valenti, and S. Gessani Immunomodulatory effects of lactoferrin on antigen presenting cells Biochimie 91 1 2009 11 18
99. K. Radek, and R. Gallo Antimicrobial peptides: natural effectors of the innate immune system Semin Immunopathol 29 1 2007 27 43 (Pubitemid 47596388)
100. K.V. Reddy, R.D. Yedery, and C. Aranha Antimicrobial peptides: premises and promises Int J Antimicrob Agents 24 6 2004 536 547 (Pubitemid 39536106)
101. A.L. Ruissen, J. Groenink, W. van't Hof, E. Walgreen-Weterings, M.J. van, and H.A. van Veen Histatin 5 and derivatives. Their localization and effects on the ultra-structural level Peptides 23 8 2002 1391 1399 (Pubitemid 35223006)
102. U.M. Saarinen, and M.A. Siimes Iron absorption from infant milk formula and the optimal level of iron supplementation Acta Paediatr Scand 66 6 1977 719 722 (Pubitemid 8219195)
103. H. Saido-Sakanaka, J. Ishibashi, E. Momotani, and M. Yamakawa Protective effects of synthetic antibacterial oligopeptides based on the insect defensins on methicillin-resistant Staphylococcus aureus in mice Dev Comp Immunol 29 5 2005 469 477 (Pubitemid 40222055)
104. L. Seganti, A.M. Di Biase, M. Marchetti, A. Pietrantoni, A. Tinari, and F. Superti Antiviral activity of lactoferrin towards naked viruses Biometals 17 3 2004 295 299 (Pubitemid 38987153)
105. J.A. Shaeiwitz, J.B. Blair, and R.C. Ruaan Evidence that yeast cell wall debris can separate proteins by ion-exchange during cell lysis Biotechnol Bioeng 34 1 1989 137 140
106. Y. Shai Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides Biochim Biophys Acta 1462 1-2 1999 55 70
107. S. Sharma, I. Verma, and G.K. Khuller Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis Antimicrob Agents Chemother 45 2 2001 639 640 (Pubitemid 32105312)
108. I. Shinoda, M. Takase, Y. Fukuwatari, S. Shimamura, M. Koller, and W. Konig Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes Biosci Biotechnol Biochem 60 3 1996 521 523 (Pubitemid 126460945)
109. M.A. Siimes, L. Salmenpera, and J. Perheentupa Exclusive breast-feeding for 9 months: risk of iron deficiency J Pediatr 104 2 1984 196 199 (Pubitemid 14188923)
110. N. Sitaram Antimicrobial peptides with unusual amino acid compositions and unusual structures Curr Med Chem 13 6 2006 679 696
111. B. Skerlavaj, D. Romeo, and R. Gennaro Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins Infect Immun 58 11 1990 3724 3730 (Pubitemid 20353375)
112. G. Spik, B. Brunet, C. Mazurier-Dehaine, G. Fontaine, and J. Montreuil Characterization and properties of the human and bovine lactotransferrins extracted from the faeces of newborn infants Acta Paediatr Scand 71 6 1982 979 985 (Pubitemid 12006573)
113. G. Stefanova, M. Vlahova, and A. Atanassov Production of recombinant human lactoferrin from transgenic plants Biol Plant 52 3 2008 423 428
114. L. Steinstraesser, T. Koehler, F. Jacobsen, A. Daigeler, O. Goertz, and S. Langer Host defense peptides in wound healing Mol Med 14 7-8 2008 Jul 528 537
115. L. Steinstraesser, U. Kraneburg, F. Jacobsen, and S. Al-Benna Host defense peptides and their antimicrobial-immunomodulatory duality Immunobiology 216 3 2011 322 333
116. L. Steinstraesser, A. Ring, R. Bals, H.U. Steinau, and S. Langer The human host defense peptide LL37/hCAP accelerates angiogenesis in PEGT/PBT biopolymers Ann Plast Surg 56 1 2006 93 98 (Pubitemid 43042282)
117. A.A. Strømstedt, L. Ringstad, A. Schmidtchen, and M. Malmsten Interaction between amphiphilic peptides and phospholipid membranes Curr Opin Colloid Interface Sci 15 6 2010 467 478
118. J. Svenson, V. Vergote, R. Karstad, C. Burvenich, J.S. Svendsen, and S.B. De Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability J Pharmacol Exp Ther 332 3 2010 1032 1039
119. T. Tokle, and D.J. McClements Physicochemical properties of lactoferrin stabilized oil-in-water emulsions: effects of pH, salt and heating Food Hydrocolloids 25 5 2011 976 982
120. S. Tomita, N. Shirasaki, H. Hayashizaki, J. Matsuyama, Y. Benno, and I. Kiyosawa Binding characteristics of bovine lactoferrin to the cell surface of Clostridium species and identification of the lactoferrin-binding protein Biosci Biotechnol Biochem 62 8 1998 1476 1482 (Pubitemid 128475069)
121. A. Tossi, and L. Sandri Molecular diversity in gene-encoded, cationic antimicrobial polypeptides Curr Pharm Des 8 9 2002 743 761 (Pubitemid 34498563)
122. F.J. Troost, W.H. Saris, and R.J. Brummer Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers Eur J Clin Nutr 57 12 2003 1579 1585 (Pubitemid 38016591)
123. H. Tsuda, T. Kozu, G. Iinuma, Y. Ohashi, Y. Saito, and D. Saito Cancer prevention by bovine lactoferrin: from animal studies to human trial Biometals 23 3 2010 399 409
124. A. Tursi, W. Elisei, G. Brandimarte, G.M. Giorgetti, M.E. Modeo, and F. Aiello Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection Med Sci Monit 13 4 2007 CR187 CR190
125. P.H. van Berkel, M.M. Welling, M. Geerts, H.A. van Veen, B. Ravensbergen, and M. Salaheddine Large scale production of recombinant human lactoferrin in the milk of transgenic cows Nat Biotechnol 20 5 2002 484 487 (Pubitemid 34495935)
126. A.M. van der Does, S.J. Bogaards, L. Jonk, M. Wulferink, M.P. Velders, and P.H. Nibbering The human lactoferrin-derived peptide hLF1-11 primes monocytes for an enhanced TLR-mediated immune response Biometals 23 3 2010 493 505
127. A.M. van der Does, S.J. Bogaards, B. Ravensbergen, H. Beekhuizen, J.T. van Dissel, and P.H. Nibbering Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens Antimicrob Agents Chemother 54 2 2010 811 816
128. M.I. van der Kraan, K. Nazmi, H.W. van't, A.V. Amerongen, E.C. Veerman, and J.G. Bolscher Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference Biochem Cell Biol 84 3 2006 358 362 (Pubitemid 44341311)
129. M.I. van der Kraan, M.J. van, K. Nazmi, J. Groenink, H.W. van't, and E.C. Veerman Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli Peptides 26 9 2005 1537 1542 (Pubitemid 41169745)
130. B.W. van der Strate, L. Beljaars, G. Molema, M.C. Harmsen, and D.K. Meijer Antiviral activities of lactoferrin Antiviral Res 52 3 2001 225 239 (Pubitemid 33000113)
131. B.W. van der Strate, F.M. De Boer, H.I. Bakker, D.K. Meijer, G. Molema, and M.C. Harmsen Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro Antiviral Res 58 2 2003 159 165 (Pubitemid 36559610)
132. W.J. van der Velden, N.M. Blijlevens, and J.P. Donnelly The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation Transpl Infect Dis 10 2 2008 80 89 (Pubitemid 351393084)
133. W.J. Velden, T.M. van Iersel, N.M. Blijlevens, and J.P. Donnelly Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) BMC Med 7 2009 44
134. M.P. Venkatesh, and L. Rong Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis J Med Microbiol 57 Pt 9 2008 1113 1121
135. H. Wakabayashi, S. Abe, T. Okutomi, S. Tansho, K. Kawase, and H. Yamaguchi Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents Microbiol Immunol 40 11 1996 821 825 (Pubitemid 27034132)
136. Y.Z. Wang, T.Z. Shan, Z.R. Xu, J. Feng, and Z.Q. Wang Effects of the lactoferrin (LF) on the growth performance, intestinal microflora and morphology of weanling pigs Animal Feed Sci Technol 135 3-4 2007 263 272 (Pubitemid 46670627)
137. P.P. Ward, E. Paz, and O.M. Conneely Multifunctional roles of lactoferrin: a critical overview Cell Mol Life Sci 62 22 2005 2540 2548 (Pubitemid 41721229)
138. M.M. Welling, P.S. Hiemstra, M.T. van den Barselaar, A. Paulusma-Annema, P.H. Nibbering, and E.K. Pauwels Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation J Clin Invest 102 8 1998 1583 1590 (Pubitemid 28492226)
139. M.M. Welling, A. Paulusma-Annema, H.S. Balter, E.K. Pauwels, and P.H. Nibbering Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations Eur J Nucl Med 3 2000 292 301 (Pubitemid 30167699)
140. D. Yamamoto, Y. Shinohara, H. Nagadome, and Y. Terada Development of tissue conditioner capable of binding with anti-microbial protein lactoferrin J Prosthodont Res 53 3 2009 136 141
141. N. Yang, M.B. Strom, S.M. Mekonnen, J.S. Svendsen, and O. Rekdal The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells J Pept Sci 10 1 2004 37 46 (Pubitemid 38100727)
142. P. Yu, D.S. van der Linden, H. Sugiarto, and R.C. Anderson Antimicrobial peptides isolated from the blood of farm animals Anim Prod Sci 50 7 2010 660 669
143. T. Zagulski, P. Lipinski, A. Zagulska, and A. Jarzabek Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system Int J Exp Pathol 79 2 1998 117 123 (Pubitemid 28219192)
144. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 6870 2002 389 395 (Pubitemid 34100944)
145. M. Zimecki, A. Wlaszczyk, R. Wojciechowski, J. Dawiskiba, and M. Kruzel Lactoferrin regulates the immune responses in post-surgical patients Arch Immunol Ther Exp (Warsz) 49 4 2001 325 333 (Pubitemid 33086306)